This trial looks at whether giving sufentanil to patients in the emergency department for pain relief works better than standard care.
- Traumatic Injury
0 Primary · 16 Secondary · Reporting Duration: at 30 minutes following administration and every 30 minutes up to 120 minutes
2 Treatment Groups
1 of 2
1 of 2
150 Total Participants · 2 Treatment Groups
Primary Treatment: Sufentanil 30 MCG Sublingual Tablet · No Placebo Group · Phase 3
Who is running the clinical trial?
Age 18 - 70 · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there any more slots available for volunteers in this experiment?
"Yes, as of 8/23/2022 this study is looking for patients to enroll. The first posting was on 8/5/2022." - Anonymous Online Contributor
What is the uppermost limit to how many people can be a part of this test simultaneously?
"That is correct. The information provided on clinicaltrials.gov does show that the study is still recruiting patients. 150 participants are needed in total, and recruitment will take place at a single site." - Anonymous Online Contributor
Are people of age for this trial being accepted?
"This study includes all patients that are aged 18-70, as specified in the enrollment requirements." - Anonymous Online Contributor
What are the risks associated with taking Sufentanil 30 MCG Sublingual Tablet?
"Given that this is a Phase 3 trial with some data supporting efficacy as well as multiple rounds of data affirming safety, our team at Power has given Sufentanil 30 MCG Sublingual Tablet a score of 3 for safety." - Anonymous Online Contributor
Which type of patient would be the best fit for this trial?
"This study is seeking to enroll 150 individuals who have recently experienced a traumatic injury and are aged between 18-70. The most important requirements for participants are: that they must be trauma patients (Level I, II or III), in need of pain treatment as indicated by an NRS score of ≥ 50, and have been in the Emergency Department for more than 30 minutes following informed consent." - Anonymous Online Contributor